AI assistant
Sending…
Forte Biosciences, Inc. — Director's Dealing 2018
Jun 25, 2018
33769_dirs_2018-06-25_39004a5b-1acf-4a19-810f-b036d498bc37.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2018-06-21
Reporting Person: BERGER FRANKLIN M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-21 | Stock option (right to buy) | $8.98 | A | 20000 | Acquired | 2028-06-20 | Common Stock (20000) | Direct |
Footnotes
F1: The stock option vests and becomes exercisable in 12 monthly installments following the date of grant.
More from Forte Biosciences, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Jan 29
Major Shareholding Notification
2026
Jan 20
Director's Dealing
2026
Jan 13
Director's Dealing
2026
Jan 13
Major Shareholding Notification
2026
Jan 9